Replies to post #93744 on Biotech Values

[Mpower]

MNTA - head of FDA biogeneric division may feel compelled to approve TEVA and MNTA's mL (multi-generic scenario) ... purely due to FDA politics. I still think MNTA would be worth 30$-40$ in such a scenario.